Taiwanese drug maker Adimmune Corp. on Thursday said it has started the first phase of human trials for its experimental COVID-19 vaccine this week, with Phase 2 likely to follow in November if everything goes well.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Lai government to seek constitutional ruling on pension reform bill
12/26/2025 10:22 PM - Politics
Cabinet aims to tighten rules on lawmaker, civil servant China visits
12/26/2025 09:33 PM - Society
Man detained after sickle attack in Miaoli
12/26/2025 09:20 PM - Politics
Taiwan's Legislature passes basic law on youth affairs
12/26/2025 09:14 PM - Business
Taiwan set to open 1st overseas recruitment center
12/26/2025 09:07 PM